Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
Sales | 1,808 | 2,288 | 1,641 | 1,952 | 335 |
Gross Profit | 1,808 | 2,288 | 1,641 | 1,960 | 330 |
Operating Expenses | 2,788 | 3,620 | 2,977 | 2,420 | 2,530 |
Operating Income | -980 | -1,332 | -1,336 | -468 | -2,195 |
Interest Expense | 1 | 1 | 1 | 0 | 1 |
Other Income | 1 | 1 | 1 | 28 | -4 |
Pre-tax Income | -980 | -1,332 | -1,336 | -440 | -2,200 |
Net Income Continuous | -980 | -1,332 | -1,336 | -441 | -2,206 |
Net Income | $-980 | $-1,332 | $-7,424 | $-441 | $-2,206 |
EPS Basic Total Ops | -0.06 | -0.08 | -0.08 | -0.03 | -0.15 |
EPS Basic Continuous Ops | -0.06 | -0.08 | -0.08 | -0.03 | -0.15 |
EPS Diluted Total Ops | -0.06 | -0.08 | -0.43 | -0.03 | -0.15 |
EPS Diluted Continuous Ops | -0.06 | -0.08 | -0.08 | -0.03 | -0.15 |
EBITDA(a) | $-795 | $-1,162 | $-1,180 | $-313 | $-2,075 |